The decrease in BRCA1 gene promoter methylation and expression by genistein in breast cancer cells was also attributed to a decrease in DNMT1 expression both in vitro (MCF7, UACC3199, and HCC38 cell lines) and in vivo (BRCA1 F22/24 mice) [181,182]. This evidence concerns the gene BRCA1 and breast carcinoma.